This federal contract award, valued at $3,567.20, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Vyvanse 30 mg capsules. The contract is a firm fixed-price delivery order with an ultimate completion date of April 16, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp is the prime contractor and holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle with a performance period extending through December 2026. This contract enables Amerisourcebergen to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers including the Defense Health Agency and U.S. Coast Guard.
Generated 7/15/25, 3:35 PM